Who is sponsoring NCT05648461?

NCT05648461 is sponsored by All India Institute of Medical Sciences.

What drugs are being tested in NCT05648461?

Interventions in NCT05648461: Five fraction of post operative radiotherapy.

What condition does NCT05648461 study?

NCT05648461 studies Head and Neck Cancer.

Is NCT05648461 still recruiting?

NCT05648461 is currently status unknown. Last updated 13 December 2022.

Last reviewed 2022-12-13 · How we verify

NCT05648461: Accelerate

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase II Study Exploring Five Fractions of Post-operative Radiation Therapy in Head and Neck Cancer

Status unknown NA Last updated 13 December 2022

What this trial tests

NA trial testing Five fraction of post operative radiotherapy in Head and Neck Cancer in 50 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
29 February 2024

1 February 2026

Quick facts

Lead sponsor	All India Institute of Medical Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 March 2023
Primary completion	29 February 2024
Estimated completion	1 February 2026
Sites	1 location across India

Drugs / interventions tested

Five fraction of post operative radiotherapy

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

All India Institute of Medical Sciences

Who can join

Adults 18 to 80, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers. The present study is a non -randomized phase II study that will enroll 50 patients and test feasibility of 30 Gy in 5 fractions of the primary disease and ipsilateral level I-III disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Moon DH, Avkshtol V, Vo D, Ahn C, et al · · 2024 · cited 3× · PMID 37380084 · DOI 10.1016/j.ijrobp.2023.06.010

Verify or expand the search:

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other All India Institute of Medical Sciences trials

Trials by the same sponsor.

NCT07515222 — Efficacy of Yoga-Based Intervention in Improving Mother-Child Bonding in Maternal Depression · NA · not yet recruiting
NCT07500870 — Comparative Evaluation of Endodontic Instrumentation Kinematics and Cryotherapy on Post-endodontic Pain and Periapical H · NA · active not recruiting
NCT06895252 — A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno · NA · recruiting
NCT06890650 — A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno · NA · recruiting
NCT06890637 — A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Diseas · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05648461 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by All India Institute of Medical Sciences
Last refreshed: 13 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05648461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing